Trials / Recruiting
RecruitingNCT05335252
Dronabinol After Arthroscopic Surgery
Dronabinol for the Treatment of Postoperative Pain After Arthroscopic Surgery: a Pilot Randomized Trial
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Northwestern University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the proposed study is to evaluate the efficacy of dronabinol for postoperative pain after arthroscopic surgery of the knee. The investigators hypothesize that dronabinol will relieve pain, reduce opioid consumption and will result in few negative side effects. If this pilot study shows promising results the investigators will expand the trial to include additional arthroscopic surgeries (hip, shoulder) and other types of orthopaedic surgery.
Conditions
- Knee Osteoarthritis
- Knee Injuries
- Meniscus Tear
- Synovitis of Knee
- Knee Ligament Injury
- Chondral Injury of Left Knee
- Chondral Injury of Right Knee
- Loose Body Knee
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dronabinol | 5mg 2x daily for 7 days |
| DRUG | Placebo | 1 caplet 2x daily for 7 days |
Timeline
- Start date
- 2022-06-28
- Primary completion
- 2026-12-01
- Completion
- 2027-06-01
- First posted
- 2022-04-19
- Last updated
- 2025-04-29
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05335252. Inclusion in this directory is not an endorsement.